These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22540836)

  • 1. Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH).
    Hjelkrem M; Morales A; Williams CD; Harrison SA
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1416-23. PubMed ID: 22540836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: a favorable endogenous response.
    Kumar R; Rastogi A; Maras JS; Sarin SK
    Clin Biochem; 2012 Feb; 45(3):272-4. PubMed ID: 22198578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children.
    Puri K; Nobili V; Melville K; Corte CD; Sartorelli MR; Lopez R; Feldstein AE; Alkhouri N
    J Pediatr Gastroenterol Nutr; 2013 Jul; 57(1):114-8. PubMed ID: 23518490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis.
    Salomone F; Li Volti G; Rosso C; Grosso G; Bugianesi E
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1202-8. PubMed ID: 23425054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unconjugated hyperbilirubinemia in nonalcoholic steatohepatitis--is it Gilbert's syndrome?
    Duseja A; Das A; Das R; Dhiman RK; Chawla Y; Bhansali A
    Trop Gastroenterol; 2005; 26(3):123-5. PubMed ID: 16512459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver disease.
    Chandok N; Minuk G; Wengiel M; Uhanova J
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):53-8. PubMed ID: 22457860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
    Domanski JP; Park SJ; Harrison SA
    J Clin Gastroenterol; 2012; 46(5):427-30. PubMed ID: 22469639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the non-alcoholic fatty liver disease activity score.
    Hjelkrem M; Stauch C; Shaw J; Harrison SA
    Aliment Pharmacol Ther; 2011 Jul; 34(2):214-8. PubMed ID: 21585409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
    Stefano JT; de Oliveira CP; Corrêa-Giannella ML; Soares IC; Kubrusly MS; Bellodi-Privato M; de Mello ES; de Lima VM; Carrilho FJ; Alves VA
    Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitis.
    El Bassat H; Ziada DH; Hasby EA; Nagy H; Abo Ryia MH
    Arab J Gastroenterol; 2014 Mar; 15(1):6-11. PubMed ID: 24630506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.
    Papatheodoridis GV; Chrysanthos N; Cholongitas E; Pavlou E; Apergis G; Tiniakos DG; Andrioti E; Theodossiades G; Archimandritis AJ
    J Hepatol; 2009 Nov; 51(5):931-8. PubMed ID: 19726097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
    Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
    Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease.
    Smith DL; Shire NJ; Watts NB; Schmitter T; Szabo G; Zucker SD
    J Clin Densitom; 2006; 9(1):105-13. PubMed ID: 16731439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease.
    Ma H; Gomez V; Lu L; Yang X; Wu X; Xiao SY
    J Gastroenterol Hepatol; 2009 Feb; 24(2):233-7. PubMed ID: 18713296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.
    Musso G; Gambino R; Cassader M; Pagano G
    Ann Med; 2011 Dec; 43(8):617-49. PubMed ID: 21039302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
    Boza C; Riquelme A; Ibañez L; Duarte I; Norero E; Viviani P; Soza A; Fernandez JI; Raddatz A; Guzman S; Arrese M
    Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease.
    Tarantino G; Colao A; Capone D; Conca P; Tarantino M; Grimaldi E; Chianese D; Finelli C; Contaldo F; Scopacasa F; Savastano S
    J Biol Regul Homeost Agents; 2011; 25(1):47-56. PubMed ID: 21382273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.